Regulation of Fibre Contraction in a Rat Model of Myocardial Ischemia by Han, Young Soo & Ogut, Ozgur
Regulation of Fibre Contraction in a Rat Model of
Myocardial Ischemia
Young Soo Han, Ozgur Ogut*
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, United States of America
Abstract
Background: The changes in the actomyosin crossbridge cycle underlying altered contractility of the heart are not well
described, despite their importance to devising rational treatment approaches.
Methodology/Principal Findings: A rat ischemia–reperfusion model was used to determine the transitions of the
crossbridge cycle impacted during ischemia. Compared to perfused hearts, the maximum force per cross-sectional area and
Ca
2+ sensitivity of fibers from ischemic hearts were both reduced. Muscle activation by photolytic release of Ca
2+ and ATP
suggested that the altered contractility was best described as a reduction in the rate of activation of noncycling actomyosin
crossbridges to activated, cycling states. More specifically, the apparent forward rate constant of the transition between the
nonforce bearing A-M.ADP.Pi state and the bound, force bearing AM*.ADP.Pi state was reduced in ischemic fibers,
suggesting that this transition is commensurate with initial crossbridge activation. These results suggested an alteration in
the relationship between the activation of thin filament regulatory units and initial crossbridge attachment, prompting an
examination of the post-translational state of troponin (Tn) T and I. These analyses indicated a reduction in the
diphosphorylated form of TnT during ischemia, along with lower Ser23/24 phosphorylation of TnI. Treatment of perfused
fibers by 8-Br-cAMP increased Ser23/24 phosphorylation of TnI, altering the reverse rate constant of the Pi isomerization in a
manner consistent with the lusitropic effect of b-adrenergic stimulation. However, similar treatment of ischemic fibers did
not change TnI phosphorylation or the kinetics of the Pi isomerization.
Conclusions: Ischemia reduces the isomerization from A-M.ADP.Pi to AM*.ADP.Pi, altering the kinetics of crossbridge
activation through a mechanism that may be mediated by altered TnT and TnI phosphorylation.
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Introduction
Cardiac muscle activation is regulated by the troponin complex,
which confers Ca
2+ sensitivity to the actomyosin (AM) crossbridge
cycle responsible for force production [1]. Under normal
physiological conditions, crossbridge cycling models suggest that
cardiac muscle actomyosin may produce force in at least two
distinct steps: i) a transition between two post-ATP hydrolysis
states, A-M.ADP.Pi P AM*.ADP.Pi and ii) release of Pi from the
AM*.ADP.Pi state to yield AM*.ADP [2–7]. With a transient or
chronic reduction of blood flow to the heart, cardiac muscle force
production is impaired regardless of ATP or Ca
2+ availability,
suggesting that the depression of force is produced in part by
intrinsic changes to the contractile filaments [8–14]. These
alterations to the contractile filaments involve both thick and thin
filament proteins, and additionally implicate accompanying
alterations in the upstream signaling mechanisms [15–17].
Therefore, the relationship between altered contractile protein
phosphorylation and the actomyosin crossbridge cycle is of
significant interest in defining the mechanisms leading to reduced
contractility with altered blood flow.
To determine the transitions of the actomyosin crossbridge cycle
altered by reduced blood flow, we examined the impact of the
ATP hydrolysis products ADP and Pi on steady state and transient
force production of fibers prepared from an in vivo ischemia –
reperfusion model [11]. The effect of Pi on ischemic fibers was
quantitatively unique compared to perfused and ischemia –
reperfused fibers, suggesting that Pi-bound states of the actomyosin
crossbridge cycle were differentially impacted with ischemia.
Transient kinetics examined by flash photolysis suggest that the
initial rate of crossbridge attachment is reduced, resulting in a
smaller number of active heads during ischemia. The reduction in
contractility during ischemia was accompanied by changes in the
phosphorylation states of the troponin subunits troponin T and I
(TnT, TnI). These results provide further insight into the
mechanisms behind reduced contractility during ischemia, high-
lighting the close relationship between thin filament protein
phosphorylation and the actomyosin crossbridge cycle.
Materials and Methods
Rat Model of Ischemia – Reperfusion and Fiber
Preparation
This model was described in detail previously [11], following a
protocol approved by the Institutional Animal Care and Use
Committee of the Mayo Clinic. Briefly, adult male Sprague-Dawley
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ketamine and xylazine (5:2; 0.520.7 mL/kg) administered intra-
muscularly. The heart was exposed by a midline thoracotomy, and
a ligature was placed near the bifurcation of the leftcoronary artery,
restricting flow through the left anterior descending and circumflex
artery. The ends wereexteriorized and passed through polyethylene
tubing. Coronary occlusion was achieved by pressing the tube
against the heart muscle while pulling the ligature. Reflow was
initiated by releasing the ligature. The following experimental
conditions were tested: 90 minutes of perfusion, 30 minutes of
occlusion (ischemia), or 30 minutes of ischemia followed by 60
minutes of reperfusion. Following the procedure, the anterolateral
papillary muscle was recovered, as its perfusion is dependent on
blood flow through the branches of the left coronary [18]. The
anterolateral papillary muscle was gently teased into thin strips in
pCa8.0 (1610
28 M free Ca
2+) relaxing solution while on ice. The
fibers were typically ,250 mm in diameter and ,1.5 mm in length.
Prepared fibers were permeabilized for 2 h at 4uC with pCa8.0
relaxing solutioncontaining1%TritonX-100.To test the impact of
cAMP-dependent protein kinase (PKA) activation on perfused and
ischemic anterolateral papillary muscle fibers, the cell permeable
analog 8-Br-cAMP (1 mM, Calbiochem) was included during the
permeabilization step.
Experimental Setup and Protocols
The workstation to test permeabilized fiber contraction has been
described previously [11], and employs an AE801 force transducer
(SensoNor, Norway) opposite a model 312C length controller
(0.25 ms length step response time; Aurora Scientific, Canada). The
ends of the permeabilized fibers are fixed with glutaraldehyde,
followed by attachment of aluminum T-clips [11]. Measurements
based on controlling the length of the fiber were programmed using
the 600A Controller software (Aurora Scientific) and data were
typically collected at 1000 Hz. Temperature of the solutions during
experiments was maintained at 1560.1uC. Solutions to activate and
relax fibers contained 5 mM free MgATP, 1 mM free Mg
2+,
10 mM total EGTA, 25 mM total BES, pH 7, and when
appropriate, 25 mM creatine phosphate and 15 units/mL creatine
kinase. Ionic strength was maintained at 200 mM using potassium
methanesulphonate. Activating solutions of varying free Ca
2+ were
prepared using an iterative program [11]. For experiments testing
the effect of ADP, 1 mM total ADP was included in the activating
solutions while maintaining ionic strength at 200 mM. For
experiments testing the effect of phosphate, varying volumes of
1 M phosphate buffer, pH 7, were added to ensure the desired final
concentration, with appropriate adjustments to maintain ionic
strength at 200 mM. All chemicals were the highest grade from
Sigma, except for ATP (Special Quality, ,0.5% ADP, Roche) and
photolysis compounds (Invitrogen).
To test fiber mechanics, an initial control contraction was
recorded from each fiber by changing the bathing solution from
pCa8.0 to pCa4.0. To measure the force-Ca
2+ relationship, the
fibers were activated with solutions of varying free [Ca
2+] between
pCa8.0 and 4.0. For the measurement of the influence of ADP or
Pi on the force-Ca
2+ relationship, a separate batch of free [Ca
2+]
solutions were mixed including either 1 mM added ADP or 5 mM
added Pi. All forces were normalized to cross-sectional area with
the assumption that fibers were elliptical in cross-section. Data
were fit using the Hill equation to determine the concentration of
free Ca
2+ required for half-maximal force (EC50). Fiber stiffness
was measured using four consecutive fiber length releases of 0.05,
0.1, 0.15 and 0.2% [19]. The change in force per cross-sectional
area per mm change in length was plotted, and the slope of the
linear fit was recorded as the stiffness. To measure the sensitivity of
force redevelopment to increasing Pi, fibers were activated by pCa
4.5, followed by pCa4.5 solution containing 5, 10, 20 and 30 mM
total Pi. Ionic strength was maintained at 200 mM for all Pi
concentrations, although for 30 mM Pi this necessitated decreas-
ing the total creatine phosphate concentration from 25 mM to
17.5 mM. The rate constant of force redevelopment after a length
release (kF) was measured by a single exponential fit of the force
recovery profile following a 5% decrease in fiber length within
3 ms [7]. All data are presented as average 6 SEM. Statistical
comparisons between groups were performed by Student’s t-test
using a Bonferroni adjustment when multiple comparisons were
necessary between three surgery groups.
Muscle Activation by Flash Photolysis
The rate constant of force development upon flash photolysis of
NP-EGTA (kAct) was determined for perfused, ischemic and
ischemia-reperfused fibers. The fiber was placed in a pCa8.0
relaxing solution that was prepared as before except for the
substitution of 20 mM PIPES for BES and inclusion of 10 mM
dithiothreitol [20]. This was followed by incubation in a pre-
activating solution that reduced EGTA to 0.1 mM. Subsequently,
the fiber was allowed to equilibrate in a pCa6.2 solution
containing NP-EGTA (2 mM) and then briefly suspended in air
for flash photolysis using a Xe flash lamp system (Model JML-C2;
Rapp OptoElectronic, Germany). Following data recording (,1s )
the fibers were immediately returned to relaxing solution. The
ATP-dependent rate constant of force development from Ca
2+-
rigor (kATP) was measured by flash photolysis of NPE-ATP. A fiber
in pCa8.0 relaxing solution was transferred to pCa8.0 rigor
solution (0 mM ATP) including 1 unit/mL apyrase [21], and then
transferred to pCa4.5 rigor solution. Following apyrase incuba-
tion, the fiber was placed in pCa4.5 rigor solution containing
5 mM NPE-ATP and 10 mM dithiothreitol. There was no change
in force when fibers were placed into the NPE-ATP containing
rigor solution. The fiber was then suspended in air for flash
photolysis and data recording. The rate constants, kAct and kATP,
were determined from the force transients by single exponential
fits.
Troponin T and Myosin Light Chain Phosphorylation
Analysis
Two-dimensional SDS-PAGE was used to resolve TnT and
myosin light chain (MLC)-1 and -2 phosphoforms essentially as
described [22]. Proteins were extracted from the anterolateral
papillary muscle by homogenization on ice in a micro tissue grinder
using a buffer of 9 M urea, 4% (w/v) 3-([3-cholamidopropyl]
dimethylammonio)-2-hydroxy-1-propanesulfonate (CHAPS), 0.5%
(v/v) pH 3–10 immobilized pH gradient (IPG) buffer, 1 mM
EDTA, and EDTA-free Complete Protease Inhibitor (Roche,
Indianapolis, IN). Following homogenization, the insoluble debris
was cleared by centrifugation and the supernatant was processed
with the 2D Clean-Up Kit (GE Lifesciences). Homogenates were
then added to a rehydration solution containing 9 M urea, 2%
(w/v) CHAPS, 0.5% (v/v) 3.5 - 5 IPG buffer, 0.002% (w/v)
bromophenol blue and protease inhibitor and used to rehydrate
7 cmpH 3-5.6NLIPGgelstrips.TheIPGstripswerefocusedinthe
‘‘face-up’’ mode on an Ettan IPGphor II Isoelectric Focusing Unit.
After the first-dimension, the gel strips were consecutively
equilibrated for 15 minutes in 6 M urea, 50 mM Bis-Tris,
pH 6.4, 30% glycerol, 2% SDS, and 0.002% bromophenol blue
containing first 10 mM dithiothreitol and then 2.5% (w/v)
iodoacetamide. Proteins on equilibrated IPG gel strips were then
resolved by second dimension SDS-PAGE using the Bis-Tris
buffering system (Invitrogen, LaJolla, CA). Resolved gels were
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using a Typhoon 9410 imager and analyzed by ImageQuant TL
software. As previously described, .95% of the TnT exists as
mono- and diphosphorylated forms of the highly abundant low Mr
isoform [22,23], and therefore the analysis focused on these two
phosphoforms.
Ser23/24 Phosphorylation of TnI
To measure the extent of Ser23/24 phosphorylation of TnI, a
multiplex Western blotting strategy was used. Samples resolved by
SDS-PAGE were transferred to PVDF membrane and incubated
simultaneously with a mouse anti-cardiac muscle TnI monoclonal
antibody (10T79E, Fitzgerald, Concord, MA) and a phospho-
Ser23/24 TnI rabbit polyclonal antibody (Cell Signaling Tech-
nology, Danvers, MA). Following washing, the blots were
incubated simultaneously with Cy3 labeled anti-mouse IgG and
Cy5 labeled anti-rabbit IgG (GE Lifesciences). Blots were scanned
on a Typhoon 9410 imager at the appropriate channels, and the
scanned images were analyzed using ImageQuant TL software.
The relative extent of Ser23/24 phosphorylation of TnI was
determined to be the Ser23/24 phosphospecific antibody signal
divided by the total TnI mAb signal for each sample. To
determine the extent of Ser23/24 phosphorylation of TnI in
perfused versus ischemic hearts, homogenates of the anterolateral
papillary muscle from five perfused hearts and five ischemic hearts
were resolved on a single gel and blotted. The extent of Ser23/24
phosphorylation in the ischemic samples was reported relative to
the perfused samples. To determine the effect of 1 mM 8-Br-
cAMP treatment on Ser23/24 phosphorylation of TnI in perfused
and ischemic rat hearts, ten fibers from the anterolateral papillary
muscle were dispersed into two groups, with one group receiving
8-Br-cAMP treatment during permeabilization and the other
group remaining untreated. All ten samples from each individual
rat were resolved on a single gel and Western blotted to measure
the extent of Ser23/24 phosphorylation of TnI. The extent of
phosphorylation in the five treated samples was reported relative
to the untreated samples. The experiments were repeated with an
independent pair of rats, resulting in measurements from two
perfused rat hearts and two ischemic rat hearts.
Phosphorylation State of Myosin Binding Protein-C
The overall phosphorylation state of the thick filament
associated protein myosin binding protein-C (MYBP-C) was
examined by sequential Pro-Q Diamond phosphoprotein and
Deep Purple total protein staining as previously described [22].
Homogenates from perfused and ischemic anterolateral papillary
muscles were resolved by 29:1 8% SDS-PAGE and initially stained
with Pro-Q Diamond phosphoprotein stain to measure an index of
phosphorylation. The gels were subsequently stained with Deep
Purple total protein stain to allow for normalization of the Pro-Q
Diamond signal according to total MYBP-C content.
Results
Ischemia-Reperfusion Reduces Force and Ca
2+ Sensitivity
An in vivo rat model was used to determine the effect of
myocardial ischemia-reperfusion on the maximum force per cross-
sectional area (Fmax), maximum fiber stiffness or the force – Ca
2+
relationship of permeabilized small fiber bundles isolated from the
anterolateralpapillary muscle.Followingthirty minutes of ischemia,
Fmax fellfrom 50.162.5 mN/mm
2 (n=12) to36.162.4 mN/mm
2
(n=12; Table 1). A subset of the fibers were used to determine the
[Ca
2+] required to achieve half-maximal force (EC50), which
increased significantly in ischemic fibers to 3.6160.11 mM( n = 8 )
compared to 3.3260.13 mM in perfused fibers (n=7). This loss of
force during ischemia was partially recovered by reperfusion to
41.365.2 mN/mm
2 (n=5) whereas the EC50 of reperfused fibers
was 3.5760.12 mM (n=5). The Hill coefficients were not different
for any of the conditions tested (data not shown). To determine if
the change in Fmax correlated with a change in crossbridge
attachment, we measured maximum stiffness per cross-sectional
area based on the assumption that measured changes in stiffness
would be proportional to the number of attached crossbridges [24].
Similar to the changes in Fmax, stiffness was significantly reduced
from 465.8663.5 mN/mm
2/mm (n=7) to 350.2640.5 mN/
mm
2/mm (n=8) with ischemia (P,0.016), and there was not full
recovery with reperfusion (408.2662.1 mN/mm
2/mm, n=5).
Effect of ADP and Pi on the Force-Ca
2+ Relationship of
Ischemia-Reperfused Fibers
We probed the ADP-dependent transition of the actomyosin
crossbridge cycle by steady state measurements of the force - Ca
2+
relationship of perfused, ischemic and ischemia - reperfused fibers
in the presence of 1 mM added ADP. In agreement with previous
studies, the addition of 1 mM ADP decreased the EC50 of fibers
from the three surgery groups [25,26]. However, the EC50 values
of perfused, ischemic and reperfused fibers in the presence of
1 mM total ADP were not significantly different from each other.
The impact of 1 mM total ADP on Fmax was not significant for
any of the surgery conditions, in general agreement with prior
Table 1. The concentrations of free Ca
2+ required for half-maximal force (EC50) and the maximal Ca
2+-activated force per cross-
sectional area (Fmax) for three surgery groups under varying experimental conditions.
Perfused Ischemic Reperfused
EC50 (mM) Control 3.3260.13 (n=7) 3.6160.11* (n=8) 3.5760.12 (n=5)
5 mM Pi 4.5260.12 (n=6) 3.8960.16
{ (n=14) 4.8760.14 (n=10)
1 mM ADP 2.2760.18 (n=10) 2.0060.20 (n=13) 2.2560.18 (n=7)
Fmax (mN/mm
2) Control 50.162.5 (n=12) 36.162.4* (n=12) 41.365.2 (n=5)
5 mM Pi 35.963.0 (n=6) 38.362.7 (n=14) 26.061.6
{ (n=10)
1 mM ADP 42.263.1 (n=10) 35.262.6 (n=13) 35.562.9 (n=7)
Data are presented as average 6 S.E.M.
*: denotes P,0.016 compared to perfused fibers under identical experimental conditions.
{: denotes P,0.016 compared to perfused and reperfused fibers under identical experimental conditions.
{: denotes P,0.016 compared to perfused and ischemic fibers under identical experimental conditions.
doi:10.1371/journal.pone.0009528.t001
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concentrations [25,27].
The phosphate-bound transitions of the crossbridge cycle were
examined at steady state by similar experiments. As expected, the
addition of 5 mM Pi decreased the Fmax of perfused fibers from
50.162.5 mN/mm
2 to 35.963.0 mN/mm
2 [4,5,25]. The pre-
dictable force response of perfused fibers to exogenous Pi was
accompanied by a general rightward shift of the EC50 of force
activation (Fig. 1B). Surprisingly, ischemic fibers demonstrated a
significantly different response to 5 mM Pi. The EC50 of ischemic
fibers in the presence of Pi (3.8960.16 mM) was significantly
different when compared to perfused (4.5260.12 mM) and
ischemia-reperfused (4.8760.14 mM) fibers. The depressive effect
of 5 mM Pi on force was recovered with reperfusion, reducing
Fmax by 37% to 26.061.6 mN/mm
2.
Effect of Increasing Pi on Fmax and the Rate Constant of
Force Redevelopment
We measured the effect of Pi on the Fmax of perfused, ischemic
and ischemia-reperfused fibers to further explore the steady state
response to exogenous Pi. We hypothesized that if the relative
insensitivity of ischemic fibers to 5 mM Pi is reflective of a change
in the rate of the transitions between Pi-bound states, then the
effect should manifest at other Pi concentrations. Fibers from a
Figure 1. Force-Ca
2+ relationships of ischemia – reperfused fibers. (A) Force per cross-sectional area versus Ca
2+ concentration for perfused
(N), ischemic (n) and ischemia-reperfused (%) fibers versus control conditions. (B) Absolute force per cross-sectional area versus Ca
2+concentration
for perfused, ischemic and ischemia – reperfused fibers in the presence of 5 mM added Pi. Data plotted are average 6 S.E.M., and the averaged data
are fit by the Hill equation for illustrative purposes. Accumulated data from all fibers are presented in Table 1.
doi:10.1371/journal.pone.0009528.g001
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pCa4.5 solutions containing 20 and 30 mM Pi. When compared
to zero added Pi, relative force declined to 61.361.7% (n=14) of
maximum in ischemic fibers as compared to 54.260.9% (n=17)
and 50.061.9% (n=12) in perfused and reperfused fibers. This
relationship was similar at 30 mM Pi, wherein the relative force
maintained was 51.361.7% (n=14) in ischemic fibers as
compared to 41.960.9% (n=17) and 40.061.5% (n=12) in
perfused and reperfused fibers, respectively. Under all cases, the
maintained relative force in ischemic fibers was significantly higher
than for perfused and reperfused fibers (P,0.016). These data
were complemented by measurements of the rate constant of force
redevelopment, kF, following a length release [7]. At zero added
Pi, kF was significantly reduced in ischemic (19.360.8 s
21) and
ischemia – reperfused fibers (20.760.6 s
21) as compared to
perfused fibers (25.961.1 s
21). For all fibers, increasing [Pi]
increased the rate of force redevelopment, but ischemic fibers had
significantly reduced rates at all Pi concentrations tested, whereas
ischemia – reperfused fibers were intermediate (Fig. 2). We fit the
Pi dependence of the force redevelopment using the relationship
kF=k 1+(k21 [Pi])/(K2+[Pi]) according to Scheme 1 [3,7]. In this
scheme, the initial attachment is commensurate with the Pi
Figure 2. Force redevelopment following length release. (A) Representative traces of force after length release for a perfused fiber activated
by pCa4.5 solution including varying concentrations of added Pi. The force recovery transients were analyzed by single exponential fits (dotted lines)
to determine the rate constant of force redevelopment. (B) The rate constant of force redevelopment for perfused (N; n=7), ischemic (n; n=10) and
ischemia-reperfused (%; n=7) fibers. Data presented are average 6 S.E.M. * P,0.016 compared to perfused.
doi:10.1371/journal.pone.0009528.g002
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for the Pi release step:
A{M:ADP:Pi
{ ?
/ {
k1
k{1
AM:ADP:Pi
{ ?
/ {
k2
k{2
AM:ADPzPi
Scheme 1
In this scheme, the necessary transition that activates cross-
bridges from non-cycling to cycling states [28] is implicit in the
first step. In ischemic fibers, both k1 and k21 were reduced
(18.960.8 s
21 and 30.761.7 s
21 respectively) versus perfused
fibers (26.660.8 s
21 and 42.363.1 s
21; P,0.016 for both
comparisons). Values were intermediate for ischemia – reperfused
fibers where k1 was 20.460.6 s
21 and k21 was 37.462.9 s
21. The
value of K2 determined from the fits was 39.464.6 mM for
perfused fibers, which was significantly higher than in ischemic
fibers (24.563.2 mM; P,0.016) but not different from ischemia-
reperfused fibers (29.463.3 mM).
Activation by Flash Photolysis
To complement the steady state measurements, we measured
the activation kinetics of fibers in response to flash photolysis of
NP-EGTA (Fig. 3) and NPE-ATP (Fig. 4) in a new cohort of rats.
Activation of perfused fibers by free Ca
2+ release following flash
photolysis of NP-EGTA resulted in a rapid rise in force, with a
maximum value of 58.064.2 mN/mm
2 and a rate constant of
22.061.2 s
21 (n=11). Both the force produced and kAct were
significantly reduced in ischemic fibers to 33.662.9 mN/mm
2 and
Figure 3. Activation of fiber contraction by Ca
2+. (A) Typical force transients from representative perfused, ischemic and ischemia-reperfused
fibers activated by Ca
2+ release following flash photolysis of NP-EGTA. Single exponential fits to the data traces are shown as dotted lines, along with
the rate constant of force activation. (B) The rate constant of force activation for perfused (n=11), ischemic (n=10) and ischemia – reperfused (n=9)
fibers activated by flash photolysis of NP-EGTA. Data are presented as average 6 S.E.M. * P,0.016 compared to perfused fibers.
doi:10.1371/journal.pone.0009528.g003
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21, respectively (n=10; P,0.016). For reperfused
fibers, the force produced and rate constant of activation were
intermediate at 42.161.6 mN/mm
2 and 19.361.6 s
21 (n=9). As
the major difference in rate and force was observed between
perfused and ischemic fibers, the NP-EGTA activation data were
complemented with NPE-ATP activation data for perfused and
ischemic fibers in Ca
2+-rigor. Force produced by transferring
perfused and ischemic fibers from relaxing to Ca
2+-rigor solution
was 18.462.2 mN/mm
2 and 11.961.5 mN/mm
2, respectively
(P,0.05). Following photolysis of NPE-ATP, there was a small,
brief drop in force prior to force activation (Fig. 4; [29,30]). The
additional active force produced from the Ca
2+-rigor level was
37.263.8 mN/mm
2 and 23.462.2 mN/mm
2 for perfused and
ischemic fibers, respectively (P,0.05). Total force produced (Ca
2+-
rigor + active) in these experiments was 55.665.8 mN/mm
2
(n=13) for perfused fibers and 35.363.5 mN/mm
2 (n=12) for
ischemic fibers. However the rate constant of force activation from
Ca
2+-rigor, kATP, was not different between perfused and ischemic
fibers, measuring 58.563.0 s
21 (n=13) and 56.362.9 s
21 (n=12)
respectively (Fig. 4). Notably, the rate constants of force activation
from the Ca
2+-rigor state by caged ATP were significantly higher
than those resulting from activation due to release of caged-Ca
2+.
Myosin Light Chain and Troponin T Phosphorylation
during Ischemia
The levels of phosphorylation of MLC-1 and MLC-2 were
determined in perfused and ischemic fibers. Both MLC-1 and
MLC-2 were present largely as nonphosphorylated and singly
Figure 4. Activation of fiber contraction by flash photolysis of NPE-ATP. (A) Typical force transients from a representative perfused and
ischemic fiber activated from Ca
2+-rigor by photoliberation of ATP from NPE-ATP. Single exponential fits to the data traces are shown as dotted lines
along with the rate constant of force activation. (B) The rate constant of force activation for perfused (n=13) and ischemic (n=12) fibers activated by
flash photolysis of NPE-ATP. Data presented are average 6 S.E.M.
doi:10.1371/journal.pone.0009528.g004
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lated form was 86.662.5% and 86.562.9% of total expression in
perfused and ischemic fibers, respectively (Table 2). Similarly,
MLC-2 was present predominantly in the nonphosphorylated
form in perfused (76.362.8%) and ischemic (73.162.7%) fibers.
When comparing the perfused to the ischemic states, there was no
statistically significant difference in the level of phosphorylation of
either light chain. To assess the phosphorylation state of TnT,
two-dimensional SDS-PAGE was used to resolve phosphoforms.
As previously demonstrated, rat cardiac TnT is expressed as two
isoforms, with the lower Mr isoform being highly abundant
[22,23]. When resolved by two-dimensional SDS-PAGE (Fig. 5A),
this abundant lower Mr TnT is expressed predominantly as two
phosphoforms that are mono- and diphosphorylated [22]. In
perfused rat hearts, the monophosphorylated TnT represented
22.162.2% (n=11) of the phosphoforms whereas the dipho-
sphorylated TnT was 77.662.3%. In ischemic fibers, the
percentage of monophosphorylated TnT increased significantly
to 39.663.0% (n=9; P,0.05) and the percentage of dipho-
sphorylated TnT decreased to 60.362.9% (Fig. 5B).
TnI and MYBP-C Phosphorylation during Ischemia
The extent of Ser23/24 phosphorylation of TnI was determined
by multiplex Western blotting of perfused and ischemic antero-
lateral papillary homogenates (Fig. 6A). Relative to the extent of
Ser23/24 phosphorylation in perfused hearts (10067.4%; n=5),
ischemic hearts demonstrated a significant decline in relative
Ser23/24 phosphorylation to 65.9616.2% (n=5; P,0.05). These
data were complemented by an examination of the phosphory-
lation state of MYBP-C as determined by phosphoprotein and
total protein staining (Fig. 6A). Relative to the level of MYBP-C
phosphorylation in perfused hearts (10069.8%, n=5), ischemic
hearts demonstrated a significant reduction (63.6615.9%, n=5;
P,0.05). As both TnI and MYBP-C are downstream targets of b-
adrenergic signaling [32], it remained possible that the reduction
in phosphorylation reflected a reduction of endogenous PKA
activity. Therefore, anterolateral papillary muscle fibers from two
perfused and two ischemic rat hearts were left untreated or treated
with 8-Br-cAMP to activate endogenous PKA. In perfused rat
hearts, the relative Ser23/24 phosphorylation level following 8-Br-
cAMP treatment increased significantly from the baseline level
(166.969.5% vs. 10067.7%, n=10 fibers from two rats; P,0.05).
However, 8-Br-cAMP treatment of anterolateral papillary muscle
fibers from ischemic rat hearts did not result in an increase in
Ser23/24 phosphorylation of TnI. In untreated ischemic fibers,
the relative level of phosphorylation was 10065.9% (n=10 fibers
from two rats) whereas treatment with 8-Br-cAMP resulted in a
relative level of 95.265.5% (Fig. 6B,C). The impact of 8-Br-cAMP
treatment on MYBP-C phosphorylation in perfused and ischemic
fibers was also analyzed (Fig. 7B,C). In contrast to TnI, treatment
of perfused fibers did not significantly increase the total
phosphorylation of MYBP-C (100613.6% vs. 105.369.3%). This
was similar to ischemic fibers wherein the total phosphorylation of
MYBP-C was not changed by 8-Br-cAMP treatment (10066.5%
vs. 10065.6%).
To determine the impact of 8-Br-cAMP treatment on the Fmax
and force redevelopment in the presence of Pi, 8-Br-cAMP treated
and untreated fibers from perfused and ischemic rat hearts were
examined (Fig. 8). Treatment of perfused fibers with 8-Br-cAMP
did not significantly influence k1 (24.460.8 s
21 vs. 25.161.1 s
21,
n=6 and 7 fibers from 2 rats, respectively) whereas k21 was
significantly increased from 36.763.0 s
21 to 49.763.9 s
21 (Fig. 7;
P,0.05). In contrast, neither k1 (21.961.0 s
21 vs 21.360.7 s
21,
n=9 fibers from 3 rats) nor k21 (23.361.5 s
21 vs 25.762.5 s
21)
was significantly influenced by 8-Br-cAMP treatment of ischemic
fibers. Compared to untreated perfused fibers, 8-Br-cAMP treated
perfused fibers trended towards higher Fmax when activated by
pCa4.5 in the presence of 0, 5, 10, 20 and 30 mM Pi. In fibers
from ischemic rat, the Fmax at all [Pi] increased significantly
following 8-Br-cAMP treatment (P,0.05).
Discussion
Deciphering the mechanisms contributing to the decline in
contractility of the heart is fundamental to developing new
treatment modalities. We have previously demonstrated that
permeabilized fibers from ischemic hearts produce submaximal
force regardless of maximum ATP or Ca
2+ availability [11].
However, the underlying causes for the change in contractility,
particularly at the level of the actomyosin crossbridge cycle, are
not well understood. To further explore this question, we used a
rat model to examine the steady state and transient contractile
response of permeabilized anterolateral papillary fiber bundles in
order to identify the transitions of the actomyosin crossbridge cycle
altered with myocardial ischemia. To probe steady state changes
in the actomyosin crossbridge cycle, force – [Ca
2+] relationships
were determined in the presence and absence of exogenous Pi and
ADP. These products of ATP hydrolysis influenced the force –
[Ca
2+] relationship of fibers generally as expected [25]. The
addition of ADP caused a significant Ca
2+-sensitization of muscle
fibers from all surgery groups, although the measured effects were
not significantly different between groups. By contrast, Pi
decreased the Ca
2+-sensitivity of force production in all surgery
groups. However, ischemic fibers better retained Ca
2+ sensitivity
and force in the presence of 5, 20 and 30 mM Pi when compared
to perfused and reperfused fibers. This distinct response suggested
that the cellular events associated with ischemia impacted the Pi-
bound states of the actomyosin crossbridge cycle. In the presence
of Pi, the higher Ca
2+-sensitivity of ischemic fibers may signal
retention of attached crossbridges through near-neighbor thin
filament regulatory unit interactions that better preserve the level
of activation [25,28,33,34]. The Pi-bound transitions of the
crossbridge cycle involve an isomerization between a low/no-
force state and an attached force-producing state that precedes Pi
release according to Scheme 1 [3–7]. The blunted effect of Pi on
ischemic fibers is consistent with the preservation of attached
crossbridges in the AM*.ADP.Pi and AM*.ADP states, whereas
similar [Pi] in perfused fibers drives a larger proportion of attached
crossbridges to detached or nonforce producing states [4,7].
To complement these steady state measurements, we examined
transient activation kinetics following photoliberation of Ca
2+ and
ATP. Both the maximum force and the rate constant of force
activation with Ca
2+,k Act, were lower for ischemic fibers as
compared to perfused fibers (Fig. 3). The rate is unlikely to be
Table 2. Phosphorylation status of MLC-1 and MLC-2 in
perfused and ischemic fibers.
MLC-1 MLC-2
Perfused (n=8) 0-P 86.662.5% 76.362.8%
1-P 13.462.5% 23.762.8%
Ischemic (n=7) 0-P 86.562.9% 73.162.7%
1-P 13.562.9% 26.962.7%
Data presented are average 6 S.E.M.
doi:10.1371/journal.pone.0009528.t002
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2+ to troponin C, as this process is at
least an order of magnitude faster than kAct [35,36]. This leaves
kAct to be limited by the rate of initial crossbridge activation and
attachment to the thin filament or the intrinsic kinetics of myosin
as it cycles between force bearing and non-force bearing states
[37]. To better discriminate which of these general processes is
impacted with ischemia, we also measured the rate constant of
force activation from Ca
2+-rigor following photoliberation of ATP
(Fig. 4). In comparison to the kAct measurement, for which
crossbridges begin in detached states, kATP measures force
activation from attached states established during Ca
2+-rigor.
Fibers in Ca
2+-rigor were expected to bypass the potential rate-
limiting effects of initial crossbridge attachment to activated thin
filament regulatory units, allowing a measurement of the rate of
force activation due directly to the cycling of activated actomyosin
crossbridges between force bearing and non-force bearing states. If
the physiological processes limiting kAct in ischemic fibers were
intrinsic to myosin and its enzymatic ATPase activity, force
activation of perfused and ischemic fibers from Ca
2+-rigor by ATP
would be expected to demonstrate different rate constants.
However, kATP was nearly identical for ischemic and perfused
fibers, suggesting that the attached myosins in these fibers had
Figure 5. Troponin T phosphorylation in perfused and ischemic fibers. (A) Two-dimensional SDS-PAGE with 3–5.6 NL IPG strips was used to
resolve TnT into its phosphoforms. Three representative perfused and ischemic samples are shown with the two predominant phosphoforms labeled
P1 (monophosphorylated) and P2 (diphosphorylated). (B) Following densitometric analysis, the percentages of monophosphorylated and
diphosphorylated TnT, as a percentage of total TnT phosphoform expression (P1 + P2), are plotted for perfused and ischemic fibers. * P,0.05
compared to the corresponding perfused phosphoform.
doi:10.1371/journal.pone.0009528.g005
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force produced following photoliberation of ATP to Ca
2+-rigor
force was ,2:1 in both perfused and ischemic fibers, suggesting
that a change in the force generated per crossbridge was unlikely.
Even when prepared from failing, explanted hearts, the unregu-
lated actomyosin ATPase of myosin is not different from myosin
prepared from nonfailing hearts [38–40], further arguing that
myosin itself is unlikely to be a primary target in the
pathophysiology of cardiovascular disease.
These fiber mechanics measurements therefore allow us to
speculate about the steps of muscle activation that limit the
magnitude and rate of force production during ischemia. Since
kATP is measured as the rate of force production from Ca
2+-rigor,
photolytic release of ATP results in an initial detachment of some
Figure 6. Phosphorylation of TnI at Ser23/24. (A) Multiplex Western blotting to determine the extent of Ser23/24 phosphorylation of TnI in five
perfused and five ischemic samples. Resolved samples were simultaneously labeled using a mouse a-TnI monoclonal antibody (Top row; Cy3 labeled
secondary antibody detection) and rabbit phospho-Ser23/24 TnI polyclonal antibody (Bottom row; Cy5 labeled secondary antibody detection). Graph
represents densitometry analysis of the Ser23/24 phosphorylated TnI signal divided by the total TnI signal. Fibers from a perfused (B) or ischemic (C)
rat heart were left untreated or treated with 8-Br-cAMP, followed by multiplex Western blotting for total and Ser23/24 phosphorylated TnI. Data
presented are average 6 S.E.M. * P,0.05 compared to the respective perfused or control condition.
doi:10.1371/journal.pone.0009528.g006
Figure 7. Phosphorylation of MYBP-C. (A) Pro-Q Diamond phosphoprotein staining (Top row) and Deep Purple total protein staining (Bottom
row) showing MYBP-C in perfused and ischemic homogenates. The graph represents the phosphoprotein signal divided by the total protein signal.
(B) Analyses of MYBP-C phosphorylation in perfused and ischemic (C) fibers with and without 8-Br-cAMP treatment. Data presented are average 6
S.E.M. * P,0.05 compared to the perfused fibers.
doi:10.1371/journal.pone.0009528.g007
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followed by reattachment to activated thin filaments and force
production (Fig. 4; [29,30]). In the current study, kATP was
measured to be significantly faster than kAct (Fig. 3) but unaltered
by ischemia. Taken together, the kATP and kAct values suggest that
the cycling rates of activated crossbridges were not rate-limiting,
but rather that the transition of non-cycling crossbridges into
activated, cycling crossbridges [28] was impaired. This is
supported by the drop in Ca
2+-rigor force in the ischemic fibres,
demonstrating that the relationship between the relief of thin
filament regulatory unit inhibition and initial crossbridge attach-
ment [3] was impaired in ischemic fibers and limited the number
of crossbridges that were able to transition from non-cycling to
cycling states. In this regard, the data in this paper are best
described by the activation and crossbridge cycling model
described by Campbell [28]. This model stipulates that non-
cycling crossbridges undergo a distinct activation transition to
enter force bearing and non-force bearing cycling states. The
separation of the activation transition from the cycling transitions
is consistent with the kATP data, whereby ischemic fibers
demonstrated reduced initial activation and attachment, manifest
as a drop in Ca
2+-rigor force, but unchanged kATP rate constants.
Figure 8. Force and rate constant of force development following 8-Br-cAMP treatment. (A) The rate constant of force redevelopment at
various [Pi] for perfused (circles) and ischemic (triangles) fibers, with (open symbols) and without (closed symbols) 8-Br-cAMP treatment. * P,0.05
compared to the control perfused condition. (B) The change in the force per cross-sectional area for perfused and ischemic fibers treated with 8-Br-
cAMP. Data presented are average 6 S.E.M. * P,0.05 compared to untreated ischemic fibers.
doi:10.1371/journal.pone.0009528.g008
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crossbridges that were able to enter the activated, cycling
population demonstrated similar transition rates between force
bearing and non-force bearing states. In contrast to kATP, the rate
constant of force production by Ca
2+ also encompasses the rate of
activation of non-cycling to cycling crossbridges. Therefore, the
reduced kAct in ischemic fibers suggests that the mechanism
governing the rate of activation from non-cycling to cycling states,
broadly represented as step 1 in Scheme 1, was impaired. The rate
constant of force development after shortening, kF, closely
resembled kAct as expected, primarily because both techniques
measure force production beginning from detached, largely non-
cycling states that must progress through an activation transition
prior to cycling between force bearing and non-force bearing
states. This is consistent with prior demonstrations that a length
release of activated fibers results in a substantially complete
crossbridge detachment and increases myoplasmic Ca
2+ [41],
reflective of Ca
2+ release from activated, Ca
2+-bound thin
filaments. This would be consistent with such regulatory units
exiting the cycling population and/or returning to the blocked
state [42], thereby needing to go through the activation transition
prior to re-entering cycling states. Therefore, force redevelopment
after the length release closely approximates force production
following flash photolysis of NP-EGTA. The small numerical
increase of kF over kAct likely reflects incomplete detachment or
incomplete return of thin filaments to the blocked state due to a
small number of persistent crossbridges that remain activated and
in cycling states [43]. These two factors likely allow for a marginal
number of crossbridges that remain activated to proceed rapidly to
cycling states to effect a minor, incremental increase in the rate
constant. Unlike kF,k ATP was not altered by ischemia, suggesting
that the reduced apparent rate constant of the Pi isomerization
measured by length release experiments (Fig. 3) is due to this step
being linked to the activation transition. Once the non-cycling to
cycling activation transition is essentially complete (as in Ca
2+-
rigor), crossbridges readily cycle between force bearing and non-
force bearing states with a higher apparent rate for k1 (Scheme 1),
allowing kATP to be faster than both kF and kAct. Therefore, at high
Ca
2+, thin filaments freely permit re-attachment of detached
crossbridges, allowing them to readily transition between force
bearing and non-force bearing states [28] at a rate that is likely
limited by transitions subsequent to the Pi isomerization [44].
Therefore, in ischemic fibers, the decline in the rate constant of
force activation following Ca
2+ release is best described as a
change in the rate of crossbridge activation into cycling states,
which itself is a function of the molecular events that facilitate thin
filament activation through an inter-related mechanism mediated
by Ca
2+ and strong crossbridge attachment [3,28,45,46]. This
scenario includes the possibility that the kAct of ischemic fibers is
slowed as a result of their reduced Ca
2+ sensitivity, which may alter
the cooperative recruitment of crossbridges into activated, cycling
states.
To begin to decipher the underlying molecular basis for reduced
contractility during ischemia, we concentrated on the regulatory
troponin complex of the thin filament. Both TnT and TnI of the
troponin complex are phosphorylated in vivo [17], leading us to
examine possible changes in their phosphorylation states with
ischemia. Analysis of TnT demonstrated a net dephosphorylation
with ischemia that resulted in an increase in the abundance of the
monophosphorylated form and an accompanying decrease in the
diphosphorylated form (Fig. 5). At this time, it is difficult to assign a
direct functional consequence to the reduction in TnT phosphor-
ylation, as there are limited data documenting the in vivo sites of
cardiac muscle TnT phosphorylation. A recent study suggested an
in vivo site of phosphorylation within the first 29 amino terminal
residues [47], and up to four sites may be phosphorylated in vitro,
with Thr206 phosphorylation having a dominant, depressive effect
on fiber contraction [48,49]. As TnT forms intimate contacts with
the tropomyosin filament, it is not unreasonable to assume that the
change in phosphorylation status may influence the state of the thin
filamentand,inturn,thetransitionofcrossbridgesfrom non-cycling
to attached, cycling states. Additional in vitro work using in vivo
phosphorylated or dephosphorylated TnT will be required to
address this mechanism.
To examine the possible impact of TnI phosphorylation, we
focused on the adjacent residues Ser23 and 24, two sites that are
especiallyrelevantforb-adrenergicsignaling.Thissignalingpathway
may be altered in heart failure through a reduction in the content of
PKAregulatorysubunits,reductioninb-adrenergicreceptordensity,
or desensitization of b-adrenergic receptors [50–52]. We examined
the extent of Ser23/24 phosphorylation and noted a relative
decrease in ischemic versus perfused fibers (Fig. 6A), consistent with
previous observations [22,50,53,54]. Although increased Ser23/24
phosphorylation of TnI is associated with decreased Ca
2+ sensitivity
under b-adrenergic stimulation [32], we observed decreased Ca
2+
sensitivity with reduced Ser23/24 phosphorylation in this and a
previous model [22], suggesting that TnI phosphorylation is not the
sole contributor to the measured EC50 in ischemic fibers. This
indicates that the integrated impact of altered TnI and TnT
phosphorylation may uniquelyalterthe EC50ofmusclecontraction.
The decreased phosphorylationofTnIwasaccompaniedbyreduced
MYBP-C phosphorylation (Fig.7),supportingthenotionthatoverall
PKA activity was impaired in response to ischemia. Therefore, the
endogenous PKA inperfused and ischemic fibers was activated by 8-
Br-cAMP and the level of Ser23/24 phosphorylation of TnI was
measured as an index of activity. As expected, 8-Br-cAMP increased
Ser23/24 phosphorylation of TnI in fibers from perfused hearts
(Fig. 6B), but there was no change in ischemic fibers (Fig. 6C).
Interestingly, the protection provided by ischemic preconditioning
has been suggested to involve early PKA activation during the
preconditioning period [55], which may then counter this observed
reduction of PKA activity during ischemia. The ability of 8-Br-
cAMP to increase Ser23/24 phosphorylation in perfused fibers
correlated with the increase in k21 w i t h o u tac h a n g ei nk 1 (Fig. 8A),
which we predict would be consistent with the lusitropic effect of b-
adrenergic stimulation [56]. This effect of 8-Br-cAMP on the Pi
isomerization rate was not observed in the ischemic fibers, consistent
with Ser23/24 phosphorylation levels remaining unchanged,
strongly suggesting that TnI phosphorylation is a modifier for this
crossbridge transition. The 8-Br-cAMP treatment also resulted in
similar relative increases in Fmax for perfused and ischemic fibers,
although only the increases in ischemic fibers reached statistical
significance (Fig. 8B). Nonetheless, the similar trends in force
production following 8-Br-cAMP treatment of perfused and
ischemic fibers contrast sharply with the observed changes in TnI
phosphorylation. This divergence likely suggests that following 8-Br-
cAMP treatment the factors responsible for controlling rate versus
force are unique. This is further strengthened by observations from
reperfused fibersdemonstrating that force recoverywasmorereadily
achieved than rate recovery (Figs. 1, 2).
At this point, it is difficult to determine how the change in
MYBP-C phosphorylation contributed to the accumulated results.
Previous studies have reported reduced MYBP-C phosphorylation
in models of altered myocardial blood flow, suggesting that this is a
conserved target [8,57,58]. In a transgenic model, Stelzer et al [59]
suggested that MYBP-C phosphorylation contributes to both
systolic and diastolic function, and we cannot exclude such a
contribution by MYBP-C phosphorylation in our mechanical
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force following 8-Br-cAMP treatment of perfused fibers (Fig. 8)
occurred without a significant change in total MYBP-C phosphor-
ylation (Fig. 7). Although MYBP-C is a proven downstream target of
b-adrenergic signaling, we do not think that the modest change in its
total phosphorylation following 8-Br-cAMP treatment is anomalous.
Previous studies have shown that following b-adrenergic stimulation
with an agonist, incorporation of
32P into MYBP-C was significantly
less in magnitude than other prominent targets such as TnI and
phospholamban [32]. This is in contrast to methods whereby an
excess of the PKA catalytic subunit is added to fibers [59], a strategy
that is unlikely to preserve the physiological framework wherein
changes in PKA subunit expression or phosphorylation state may
dictatealtered substrate selectivity [50,60].Ouruse of 8-Br-cAMPto
activate the endogenous PKA better resembles agonist-dependent
activation [32], suggesting that perfused fibers should demonstrate a
larger change in TnI versus MYBP-C phosphorylation, as observed
(Figs. 6,7). Further, given that MYBP-C is heavily phosphorylated at
baseline [8], we are not surprised that the marginal increase in total
MYBP-C phosphorylation was muted as compared to previous
methods that employed the change of
32P incorporation over
baseline [32].
In conclusion, the present study demonstrates that the
actomyosin crossbridge cycle during ischemia is unique for a
reduction in the forward rate constant of the isomerization of the
Pi-bound actomyosin transition, which may be closely linked to
the transition of non-cycling crossbridges to activated, cycling
crossbridges. Additionally, the decrease in the rate of force
activation with Ca
2+ but not ATP is reflective of altered thin
filament regulatory function and crossbridge recruitment during
ischemia that modulates the apparent rates of activation of the
actomyosin crossbridge cycle without impacting the intrinsic
activity of the myosin enzyme. The in vivo model demonstrated
reduced phosphorylation of TnT and TnI, suggesting that the
integrated effect of altered troponin phosphorylation may be
involved in the observed contractile response. Future studies will
benefit from a focus on the thin filament and the post-translational
state of regulatory proteins during ischemia in order to understand
their individual and combined contributions to pathophysiological
states marked by reduced contractility.
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